Concomitant Letrozole With Adjuvant Breast Radiotherapy Safe

With long-term follow-up, letrozole can be safely administered concomitantly with adjuvant breast radiotherapy (RT) in postmenopausal patients with stage 1 to 2 breast cancer, a study published online ahead of print in the journal Annals of Oncology has shown.1

For the phase 2 study, researchers enrolled 150 postmenopausal women with stage 1 to 2 breast cancer and randomly assigned them to receive letrozole concurrently or sequentially to adjuvant radiotherapy. Researchers also conducted sub-studies to identify patients at risk for developing radiation-induced subcutaneous fibrosis.

Results showed that at a median follow-up of 74 months, 5 patients developed grade 2 or higher radiation-induced subcutaneous fibrosis, but there were no significant differences between the 2 treatment arms. Researchers observed no grade 2 or higher lung or symptomatic cardiac toxicities.

For the sub-studies, the median radiation-induced lymphocyte apoptosis value of the patients who had developed grade 2 or higher radiation-induced subcutaneous fibrosis was 6.9% compared with 13% among those who developed grade 1 or lower radiation-induced subcutaneous fibrosis (P=.02).

The study also identified 2 single nucleotide polymorphisms associated with radiation-induced lymphocyte apoptosis, which are both located on the PHACTR3 gene on chromosome 20q13.33.

“Translational sub-studies showed that high [radiation-induced lymphocyte apoptosis] values were correlated with patients who did not develop [radiation-induced subcutaneous fibrosis],” the investigators conclude.


1. Bourgier C, Kerns S, Gourgou S, et al. Concurrent or sequential letrozole with adjuvant breast radiotherapy: Final results of the CO-HO-RT phase II randomized trial [published online ahead of print December 17, 2015]. Ann Oncol. doi:10.1093/annonc/mdv602.
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs